Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio
Novartis | October 30, 2017
Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to certain conditions.